Skip to main content

Fan Yu

SEC CIK
0001668029
Latest filing
Aug 14, 2026

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
4
−1 vs. Q3 2023
Portfolio value
$20.0M
+$18.5M (+1,315.4%) vs. Q3 2023
Filed
Feb 14, 2024
SEC
Holdings of Fan Yu in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
CRGXCARGO Therapeutics, Inc.COM822,171$19.0M95.4%+822,171NewHistory
CSTLCastle Biosciences IncCOM22,503$485.6K2.4%+22,503NewHistory
SGMTSagimet Biosciences Inc.COM SER A57,190$310.0K1.6%00.0%UnchangedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK69,303$124.7K0.6%00.0%UnchangedHistory

Sold out since Q3 2023 (3)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Fan Yu sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
SONXSonendo, Inc.COM547,945$408.7K29.0%History
SYRESpyre Therapeutics, Inc.COM20,592$347.8K24.7%History
PREPrenetics Global LtdCLASS A ORD25,000$12.1K0.9%History